---
figid: PMC8103095__EMMM-13-e12606-g003
figtitle: miR‐33 regulates hepatic lipoprotein metabolism, fibrosis, and regeneration
organisms:
- Gallus gallus
- Oncorhynchus mykiss
- Homo sapiens
- Mus musculus
- Caenorhabditis elegans
- Mycobacterium tuberculosis
- Bromelia plumieri
pmcid: PMC8103095
filename: EMMM-13-e12606-g003.jpg
figlink: /pmc/articles/PMC8103095/figure/emmm202012606-fig-0003/
number: F3
caption: Schematic overview showing the metabolic pathways regulated by miR‐33 in
  hepatocytes. Hepatic miR‐33 levels are regulated by cellular cholesterol content,
  insulin, and other factors, including lncRNA CHROME. miR‐33 controls numerous steps
  of the reverse cholesterol transport pathway, such as HDL biogenesis (ABCA1) and
  bile acid synthesis (ABCB11, ATP8B1, CYP7A1). miR‐33 also regulates the expression
  of numerous genes associated with fatty acid oxidation (CPT1A, HADHB, CROT), which
  might influence ApoB lipidation and VLDL secretion, and glucose metabolism (IRS2,
  PCK1, G6PC). Suppression of hepatic miR‐33 attenuates obesity‐driven liver fibrosis
  and promotes hepatic regeneration by enhancing fatty acid oxidation and SKI levels
  and increasing the expression of cell cycle regulators (CDK6 and CCND1), respectively.
papertitle: 'miR‐33 in cardiometabolic diseases: lessons learned from novel animal
  models and approaches.'
reftext: Nathan L Price, et al. EMBO Mol Med. 2021 May 7;13(5):e12606.
year: '2021'
doi: 10.15252/emmm.202012606
journal_title: EMBO Molecular Medicine
journal_nlm_ta: EMBO Mol Med
publisher_name: John Wiley and Sons Inc.
keywords: atherosclerosis | metabolism | miR‐33 | miRNA | Cardiovascular System |
  Chromatin, Epigenetics, Genomics & Functional Genomics | Metabolism
automl_pathway: 0.9386859
figid_alias: PMC8103095__F3
figtype: Figure
organisms_ner:
- Gallus gallus
- Homo sapiens
- Mus musculus
- Oncorhynchus mykiss
redirect_from: /figures/PMC8103095__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8103095__EMMM-13-e12606-g003.html
  '@type': Dataset
  description: Schematic overview showing the metabolic pathways regulated by miR‐33
    in hepatocytes. Hepatic miR‐33 levels are regulated by cellular cholesterol content,
    insulin, and other factors, including lncRNA CHROME. miR‐33 controls numerous
    steps of the reverse cholesterol transport pathway, such as HDL biogenesis (ABCA1)
    and bile acid synthesis (ABCB11, ATP8B1, CYP7A1). miR‐33 also regulates the expression
    of numerous genes associated with fatty acid oxidation (CPT1A, HADHB, CROT), which
    might influence ApoB lipidation and VLDL secretion, and glucose metabolism (IRS2,
    PCK1, G6PC). Suppression of hepatic miR‐33 attenuates obesity‐driven liver fibrosis
    and promotes hepatic regeneration by enhancing fatty acid oxidation and SKI levels
    and increasing the expression of cell cycle regulators (CDK6 and CCND1), respectively.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APOB
  - VLDLR
  - CROT
  - CPT1A
  - HADHB
  - HMGCR
  - SREBF2
  - MIR33A
  - IRS2
  - SREBF1
  - HSD11B1B
  - HSD11B1A
  - ABCA1
  - ATP8B1
  - CYP7A1
  - ABCB11
  - CDK6
  - CCND1
  - SKI
  - TGFB1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MIR33B
  - HSD11B1
  - ALB
  - APOA1
  - APOA2
  - APOE
  - CLU
  - F11R
  - CHROMR
  - TGFB2
  - TGFB3
  - Apob
  - Cd320
  - Crot
  - Cpt1a
  - Hadhb
  - Hmgcr
  - Srebf2
  - Irs2
  - Mir33
  - Srebf1
  - F11r
  - Abca1
  - Atp8b1
  - Cyp7a1
  - Abcb11
  - Cdk6
  - Ccnd1
  - Ski
  - Skic2
  - Tgfb1
  - Ltbp1
  - apoba
  - hadhb
  - atp8b1
  - abcb11b
  - abcb11a
  - cdk6
  - ccnd1
  - skia
---
